Home
Sessions
Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement
Magnetic Resonance Imaging (MRI) Radiomics that Predicts the Treatment Outcome in a Phase 2 Trial of Ra-223 Combined with Stereotactic Body Radiation Therapy and Androgen Deprivation Therapy (ADT) for Oligometastatic Castrate Sensitive Prostate Cancer

Sep 29

PQA 06 - Genitourinary Cancer, Gynecological Cancer, and Health Care Access and Engagement

3356 - Magnetic Resonance Imaging (MRI) Radiomics that Predicts the Treatment Outcome in a Phase 2 Trial of Ra-223 Combined with Stereotactic Body Radiation Therapy and Androgen Deprivation Therapy (ADT) for Oligometastatic Castrate Sensitive Prostate Cancer

02:15pm - 03:30pm ET

Poster Hall - Exhibit Hall A

Presenter(s)

Kun Qing, PhD - City of Hope Comprehensive Cancer Center, Duarte, CA